SSE: 688114 - MGI Tech Co., Ltd.

Yield per half year: +5.41%
Dividend yield: 0.00%
Sector: Healthcare

MGI Tech Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
22.1 41.44 -46.66% 22.88 -3.4%
P/S 12.18 20.2 -39.69%
P/BV 4.09 3.68 11.17%
P/FCF -22.23 82.02 -127.11%
Ev/Ebitda 14.98 16.62 -9.89%
Ev/S 10.46 25.64 -59.23%
Ev/FCF -18.7 85.08 -121.98%
E/P -0.0168 0.0217 -177.49%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-10.74 6.32 -269.88% 0 0%
ROE -6.73 6.65 -201.2%
ROA -5.58 3.59 -255.59%
ROIC 0 0 0%
ROS -20.87 -76.75 -72.81%
ROCE 0 19.43 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-1.02 0.7406 -237.59% -1.02 0%
Nеt Debt/Ebitda 0 -0.1122 -100%
Debt/Ratio 0.0153 0.1008 -84.83%
Debt/Equity 0 0.212 -100%
Debt/Net Income -0.2658 1.37 -119.34%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.3991 -100% 0.3797 -100%
Number of years of dividend growth 1 1 0%
DSI 0.5 0.6935 -27.9%
Average dividend growth 0 3.04 -100%
Average percentage for 5 years 0.3797 1.4 -72.83%
Average percentage for payments 9.51 45.07 -78.9%
Difference from average difference in sector -0.3991

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
1/10
4.72 23.95 -80.29%
Growth impulse Ebitda in 5 years 0 12.85 -100%
Growth impulse Net Income in 5 years -332.88 62.77 -630.32%
Growth impulse FCF in 5 years 230.21 30.35 658.52%
Growth impulse EPS in 5 years -308.31 82.9 -471.91%
IP Score
3.72/10

Similar companies

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription